Healthcare Services

Kidney Disease Market Growth Forecast With Analysis Of Industry Progress Through 2030

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Kidney Disease Market Compare Between 2026 And 2030?

The kidney disease market has experienced significant growth in recent years. It is projected to expand from $114.39 billion in 2025 to $121.98 billion in 2026, showing a compound annual growth rate (CAGR) of 6.6%. This historical development can be attributed to the escalating prevalence of chronic kidney disease, a rise in the incidence of diabetes and hypertension, the well-established utilization of dialysis and medication therapies, the expansion of hospital-based renal care, and the increasing availability of diagnostic testing.

The kidney disease market is projected for significant expansion over the coming years, with its size expected to reach $159.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is attributable to several factors, including an aging global populace with elevated renal risk, the increasing embrace of home-based dialysis solutions, heightened investment in kidney disease research, a stronger emphasis on early screening initiatives, and broadening access to renal care within developing markets. Concurrently, key trends shaping this period encompass a heightened focus on prompt detection and effective disease management, the expanding use of dialysis and renal replacement therapies, a surging demand for individualized kidney disease treatments, the development of more multidisciplinary care approaches for renal patients, and enhanced patient awareness alongside preventive health programs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Important Drivers Are Powering The Kidney Disease Market Growth?

The escalating prevalence of kidney diseases is projected to drive the growth of the kidney disease market moving forward. Kidney diseases encompass various conditions that compromise the function and structure of the kidneys. Medications for kidney disorders serve to reduce patients’ blood pressure and decrease protein loss, thereby decelerating the progression of kidney damage, managing associated symptoms, and averting potential complications. As an illustration, in June 2023, Kidney Research UK, a UK-based organization dedicated to advancing understanding, prevention, and treatment of kidney diseases, reported that an estimated 7.19 million individuals in the UK were impacted by chronic kidney disease in 2023, accounting for more than 10% of the UK population, with projections showing an increase to 7.61 million people by 2033. Thus, the heightened incidence of kidney diseases is a primary driver for the expansion of the kidney disease market.

Which Segment-Based Categories Are Covered In The Kidney Disease Market?

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Which Trends Are Shaping The Kidney Disease Market Landscape?

Key players in the kidney disease market are prioritizing the integration of technologically advanced solutions, such as compact, cartridge-based hemodialysis systems, to enhance treatment flexibility, patient usability, and workflow efficiency. These compact, cartridge-based hemodialysis systems are portable dialysis devices that employ disposable dialysate cartridges rather than conventional bagged fluids. This innovation enables features like automated dialysate preparation, simplified setup, and increased suitability for home-based therapy. For example, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, secured FDA clearance for its Quanta Dialysis System. This cartridge-based hemodialysis system is engineered to support home hemodialysis and adaptable care-setting deployment, featuring a compact footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The Quanta Dialysis System effectively improves patient autonomy, simplifies treatment delivery, and boosts operational efficiency across various dialysis settings.

Which Firms Are Competing In The Kidney Disease Market?

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Access The Complete Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Which Geographic Region Represents The Largest Kidney Disease Market Share?

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Kidney Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Browse Through More Reports Similar to the Global Kidney Disease Market 2026, By The Business Research Company

Chronic Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Diabetic Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Rare Kidney Diseases Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795